cilastatin has been researched along with Blood Poisoning in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (30.23) | 18.7374 |
1990's | 18 (41.86) | 18.2507 |
2000's | 8 (18.60) | 29.6817 |
2010's | 3 (6.98) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Bu, Y; Guo, N; Han, C; Jia, X; Li, X; Liu, X; Ma, X; Peng, Y; Wang, C; Yang, M; Yu, K; Zhang, J | 1 |
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
Deng, LY; Gong, YL; Huang, GT; Jiang, B; Peng, YZ; Yang, ZC; Yin, SP | 1 |
Aranda, F; Armiger-Borràs, N; Carrasco, E; Consuegra-Fernández, M; Di Scala, M; González-Aseguinolaza, G; Lozano, F; Martínez-Florensa, M; Pachón, J; Vila, J | 1 |
Flores, M; Murillo, J; Stumpf, PG | 1 |
Kartavenko, VI; Men'shikova, ED; Mironov, AV; Shabanov, AK; Vasina, TA | 1 |
Alvarez-Lerma, F; Blanco, A; Domínguez-Muñoz, JE; Gener, J; Maraví-Poma, E; Olaechea, P | 1 |
Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
Bochnia, M; Fraczek, M; Jankowska-Konsur, A; Jaworska, M; Kubacka, M; Mazur, M; Preś, K; Rostkowska-Nadolska, B; Steinmetz-Beck, A | 1 |
Etoh, T; Hirose, M; Ishibashi, H; Muro, H; Ohta, S; Shirasu, T; Suzuki, K; Tanio, N | 1 |
Giercksky, KE; Lundblad, R | 1 |
Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y | 1 |
Demirel, M; Eskitürk, A; Haklar, G; Işgör, A; Peker, O; Söyletir, G; Yalçin, AS | 1 |
Ariga, K; Shinagawa, N; Suzuki, K; Yamakoshi, M; Yamamoto, T | 1 |
Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
Chiritso, BG; Gal'tseva, IV; Grinev, MV; Shapot, IuB; Tsibin, IuN | 1 |
Domon, H; Furuya, N; Ishii, K; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
Hogaboam, CM; Kunkel, SL; Lukacs, NW; Steinhauser, ML; Strieter, RM | 1 |
Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
Fung, CP; Kuo, BI; Liu, CY | 1 |
Brollo, L; Dal Pos, L; Furlanut, M; Lugano, M; Pea, F | 1 |
Kuroe, K; Nakaji, S; Ogasawara, H; Saito, S; Sakata, Y; Sawada, Y; Shinagawa, H; Soma, N; Takami, H; Tsushima, K | 1 |
Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
Bom, VJ; de Vries-Hospers, HG; Dofferhoff, AS; Hazenberg, BP; Mulder, PO; van der Meer, J; van Ingen, J; Weits, J | 1 |
Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS | 1 |
Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A | 1 |
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
Giacometti, A; Petrelli, E; Pongetti, P; Scalise, G | 1 |
Aitchison, JM; Linton, DM; Potgieter, PD | 1 |
Aufrant, C; Bompard, Y; Chastel, A; Gantzer, A; Lambert, T; Voinnesson, A | 1 |
Kim, KS | 2 |
Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K | 1 |
Del Valle, J; Noriega, AR; Otero, JR; Revilla, AP; Sanz, F | 1 |
Fujita, K; Inyaku, F; Kakehashi, H; Maruyama, S; Murono, K; Ohmi, H; Sakata, H; Sanae, N; Yoshioka, H | 1 |
Horiguchi, S; Kusunoki, Y; Nagamatsu, I; Takase, A; Tateno, Y; Wagatsuma, Y | 1 |
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, P; Rolston, K; Steelhammer, L | 1 |
Cumberland, NS; Jones, KP | 1 |
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
Aebert, H; Bunzendahl, H; Hünefeld, G; Weissbrodt, H | 1 |
Eron, LJ | 1 |
1 review(s) available for cilastatin and Blood Poisoning
Article | Year |
---|---|
[A case of psoas abscess associated in the elderly].
Topics: Aged; Aged, 80 and over; Cilastatin; Diabetes Complications; Drainage; Drug Therapy, Combination; Escherichia coli Infections; Humans; Imipenem; Male; Proteus Infections; Proteus mirabilis; Psoas Abscess; Sepsis | 1996 |
17 trial(s) available for cilastatin and Blood Poisoning
Article | Year |
---|---|
Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
Topics: Aged; Antibiotic Prophylaxis; APACHE; Cause of Death; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Administration Schedule; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Incidence; Infection Control; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Severity of Illness Index; Spain; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis | 1993 |
[A trial of the clinical use of thienam in treating severe and life-threatening suppurative-septic complications].
Topics: Acute Disease; Adult; Aged; Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1996 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Topics: Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Sepsis; Thienamycins | 2000 |
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Lincomycin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Pneumonia; Sepsis; Urinary Tract Infections | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 1990 |
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis | 1990 |
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Complex; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; Sepsis | 1990 |
Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Sepsis | 1989 |
Imipenem/cilastatin therapy of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins | 1987 |
Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Thienamycins | 1987 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
25 other study(ies) available for cilastatin and Blood Poisoning
Article | Year |
---|---|
Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice.
Topics: Animals; Anti-Bacterial Agents; Cilastatin; Feces; Gastrointestinal Microbiome; Gastrointestinal Motility; Imipenem; Male; Mice; RNA, Ribosomal, 16S; Sepsis | 2021 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriophages; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Liver; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Soft Tissue Infections; Stem Cells | 2016 |
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cecum; Cilastatin; Cilastatin, Imipenem Drug Combination; Cytokines; Dependovirus; Disease Models, Animal; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Ligation; Male; Mice; Mice, Inbred C57BL; Receptors, Scavenger; Sepsis | 2017 |
Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.
Topics: Abscess; Anti-Bacterial Agents; Anticoagulants; Carrier State; Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Female; Heparin; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Puerperal Infection; Pulmonary Embolism; Radiography; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Thrombophlebitis; Vancomycin; Young Adult | 2008 |
[Antibacterial activity of imipenem/cilastatin (thienam) against agents causing pyoseptic processes].
Topics: Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Sepsis; Suppuration | 2002 |
[Sepsis in the sphenoiditis patient].
Topics: Abscess; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Middle Aged; Radiography; Sepsis; Sphenoid Sinus; Sphenoid Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
[Postoperative penicillin-resistant streptococcus pneumonia in lung cancer patient].
Topics: Aged; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Lung Neoplasms; Male; Penicillin Resistance; Pneumonia, Pneumococcal; Postoperative Complications; Sepsis; Streptococcus pneumoniae; Ventilators, Mechanical | 2008 |
Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
Topics: Animals; Antibodies, Monoclonal; Blood Volume; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelins; Fluid Therapy; Imipenem; Immunoglobulins; Male; Peritonitis; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Sepsis; Time Factors | 1995 |
The effects of experimental splenic autotransplantation and imipenem-cilastatin treatment in postsplenectomy Pseudomonas aeruginosa sepsis.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Hemoglobins; Imipenem; Immunoglobulin M; Lung; Male; Oxygen; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sepsis; Spleen; Splenectomy; Transplantation, Autologous | 1995 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Animals; Carbapenems; Cilastatin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Protease Inhibitors; Sepsis | 1998 |
Multiple roles for IL-12 in a model of acute septic peritonitis.
Topics: Acute Disease; Animals; Cecal Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Fibrosis; Imipenem; Immune Sera; Immunization, Passive; Interferon-gamma; Interleukin-10; Interleukin-12; Intestinal Perforation; Ligation; Mice; Peritoneum; Peritonitis; Sepsis; Wound Healing | 1999 |
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Hemofiltration; Humans; Imipenem; Kidney Transplantation; Male; Multiple Organ Failure; Sepsis; Serum Albumin; Teicoplanin | 2001 |
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
Topics: Acute-Phase Proteins; Cefuroxime; Cilastatin; Drug Therapy, Combination; Endotoxins; Female; Humans; Imipenem; Interleukin-1; Interleukin-6; Male; Middle Aged; Sepsis; Tobramycin; Tumor Necrosis Factor-alpha | 1991 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Sepsis; Thienamycins | 1988 |
In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
Topics: Ampicillin; Animals; Animals, Newborn; Cilastatin; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Listeria monocytogenes; Listeriosis; Liver; Meningitis, Listeria; Rats; Sepsis; Spleen; Thienamycins | 1986 |
[Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in children].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Pneumonia; Sepsis; Thienamycins; Thyroiditis; Urinary Tract Infections | 1986 |
[Clinical evaluation of imipenem/cilastatin sodium in children].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Empyema; Female; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Male; Pneumonia, Staphylococcal; Pyelitis; Sepsis; Thienamycins; Tonsillitis | 1986 |
Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pneumonia; Sepsis; Thienamycins | 1986 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
Topics: Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Thienamycins | 1986 |
Imipenem/cilastatin therapy of bacteremia.
Topics: Adolescent; Adult; Aged; Bacteria; Cilastatin; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Sepsis; Thienamycins | 1985 |
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins | 1985 |